Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
151.5 USD | -0.76% | +0.67% | +56.85% |
06-26 | Monetary policy is getting even more confusing | |
06-26 | Citigroup Downgrades Sarepta Therapeutics to Neutral From Buy, Raises Price Target to $176 From $172 | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+56.85% | 14.43B | |
+21.64% | 127B | |
+25.06% | 117B | |
+26.00% | 27.67B | |
-18.71% | 20.33B | |
-15.34% | 16.79B | |
-17.81% | 15.63B | |
+13.12% | 14.84B | |
-47.70% | 14.65B | |
+149.31% | 12.49B |
- Stock Market
- Equities
- SRPT Stock
- News Sarepta Therapeutics, Inc.
- Sarepta Therapeutics, Inc. Enters into License Agreement with Nationwide Children’S Hospital for Galgt2 Gene Therapy Program